Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Friday, July 31, 2026.
Reported quarterly profit margin; no daily interpolation. Q1 FY2027 (2026-07-31): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
0.00%
NET PROFIT MARGIN AVG 15Y
0.00%
NET PROFIT MARGIN AVG 20Y
-63.86%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
+100.00%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 752 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
PharmaCyte Biotech, Inc.
Market Cap
$4.38M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.26M
Net Profit Margin
-285.00%
TTM Avg
-249.81%
3Y Avg
-232.15%
5Y Avg
-165.63%
Market Cap
$4.53M
Net Profit Margin
-3934.91%
TTM Avg
-1854.81%
3Y Avg
-2358.55%
5Y Avg
-1587.79%
Market Cap
$4.57M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.11M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.64M
Net Profit Margin
-118.27%
TTM Avg
-13237.88%
3Y Avg
-7961.50%
5Y Avg
-5307.67%
Market Cap
$4.01M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
64.44%
5Y Avg
-64.28%
Market Cap
$4.77M
Net Profit Margin
-3985.58%
TTM Avg
-1467.13%
3Y Avg
-2181.72%
5Y Avg
-1717.85%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PharmaCyte Biotech, Inc. (PMCB) | $4.38M | 0.00% | 0.00% | 0.00% | 0.00% |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.26M | -285.00% | -249.81% | -232.15% | -165.63% |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.53M | -3934.91% | -1854.81% | -2358.55% | -1587.79% |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.57M | 0.00% | 0.00% | 0.00% | 0.00% |
| GRI Bio, Inc. (GRI)vs › | $4.16M | N/A | 0.00% | 0.00% | -421.83% |
| Processa Pharmaceuticals, Inc. (PCSA)vs › | $4.11M | 0.00% | 0.00% | 0.00% | 0.00% |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.64M | -118.27% | -13237.88% | -7961.50% | -5307.67% |
| Aptevo Therapeutics Inc. (APVO)vs › | $4.01M | 0.00% | 0.00% | 64.44% | -64.28% |
| Lexaria Bioscience Corp. (LEXX)vs › | $4.77M | -3985.58% | -1467.13% | -2181.72% | -1717.85% |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.88M | 0.00% | -3826.38% | -9879.36% | -6586.24% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-07-31 | 0.00% |
| 2026-04-30 | 0.00% |
| 2026-01-31 | 0.00% |
| 2025-10-31 | 0.00% |
| 2025-07-31 | 0.00% |
| 2025-04-30 | 0.00% |
| 2025-01-31 | 0.00% |
| 2024-10-31 | 0.00% |
| 2024-07-31 | 0.00% |
| 2024-04-30 | 0.00% |
| 2024-01-31 | 0.00% |
| 2023-10-31 | 0.00% |
| 2023-07-31 | 0.00% |
| 2023-04-30 | 0.00% |
| 2023-01-31 | 0.00% |
| 2022-10-31 | 0.00% |
| 2022-07-31 | 0.00% |
| 2022-04-30 | 0.00% |
| 2022-01-31 | 0.00% |
| 2021-10-31 | 0.00% |
| 2021-07-31 | 0.00% |
| 2021-04-30 | 0.00% |
| 2021-01-31 | 0.00% |
| 2020-10-31 | 0.00% |
| 2020-07-31 | 0.00% |
| 2020-04-30 | 0.00% |
| 2020-01-31 | 0.00% |
| 2019-10-31 | 0.00% |
| 2019-07-31 | 0.00% |
| 2019-04-30 | 0.00% |
| 2019-01-31 | 0.00% |
| 2018-10-31 | 0.00% |
| 2018-07-31 | 0.00% |
| 2018-04-30 | 0.00% |
| 2018-01-31 | 0.00% |
| 2017-10-31 | 0.00% |
| 2017-07-31 | 0.00% |
| 2017-04-30 | 0.00% |
| 2017-01-31 | 0.00% |
| 2016-10-31 | 0.00% |
| 2016-07-31 | 0.00% |
| 2016-04-30 | 0.00% |
| 2016-01-31 | 0.00% |
| 2015-10-31 | 0.00% |
| 2015-07-31 | 0.00% |
| 2015-04-30 | 0.00% |
| 2015-01-31 | 0.00% |
| 2014-10-31 | 0.00% |
| 2014-07-31 | 0.00% |
| 2014-04-30 | 0.00% |
| 2014-01-31 | 0.00% |
| 2013-10-31 | 0.00% |
| 2013-07-31 | 0.00% |
| 2013-04-30 | 0.00% |
| 2013-01-31 | 0.00% |
| 2012-10-31 | -6089.01% |
| 2012-07-31 | -7704.75% |
| 2012-04-30 | -7549.21% |
| 2012-01-31 | -1340.73% |
| 2011-10-31 | -2202.94% |
| 2011-07-31 | -3471.41% |
| 2011-04-30 | -2138.07% |
| 2011-01-31 | -387.55% |
| 2010-10-31 | -288.74% |
| 2010-07-31 | -498.00% |
| 2010-04-30 | -5485.01% |
| 2010-01-31 | -2572.27% |
| 2009-10-31 | -732.99% |
| 2009-07-31 | -1215.49% |
| 2009-04-30 | -5763.89% |
| 2009-01-31 | -667.80% |
| 2008-10-31 | -211.50% |
| 2008-07-31 | -171.79% |
| 2008-04-30 | -460.40% |
| 2008-01-31 | -304.77% |
| 2007-10-31 | -270.65% |
| 2007-07-31 | -279.32% |
| 2007-04-30 | -184.85% |
| 2007-01-31 | -931.13% |
| 2006-10-31 | -318.52% |
| 2006-07-31 | -298.41% |
| 2006-04-30 | -1272.00% |
| 2006-01-31 | -627.96% |
| 2005-10-31 | 0.00% |
| 2005-07-31 | -1378.11% |
| 2005-04-30 | -5445.13% |
| 2005-01-31 | -1750.43% |
| 2004-10-31 | -53892.04% |
| 2004-07-31 | -1992.75% |
| 2004-04-30 | 0.00% |
| 2004-01-31 | 0.00% |
| 2003-10-31 | 0.00% |
| 2003-07-31 | 0.00% |
| 2003-04-30 | 0.00% |
| 2003-01-31 | 0.00% |
